Sales 2024 * | 101M 138M | Sales 2025 * | 113M 154M | Capitalization | 187M 255M |
---|---|---|---|---|---|
Net income 2024 * | -13M -17.79M | Net income 2025 * | -10M -13.68M | EV / Sales 2024 * | 1.85 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
-13.7
x | P/E ratio 2025 * |
-17.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.3% |
Latest transcript on OptimizeRx Corporation
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | 01-23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
1st Jan change | Capi. | |
---|---|---|
+30.11% | 451B | |
+15.93% | 149B | |
+10.85% | 95.8B | |
+26.31% | 88.89B | |
+70.98% | 63.95B | |
+13.34% | 45.83B | |
+17.79% | 33.51B | |
-15.44% | 30.19B | |
+21.44% | 30.73B |